Cargando…

Neuroendocrine Assessment of Dopaminergic Function during Antidepressant Treatment in Major Depressed Patients

The effects of antidepressants on dopamine (DA) receptor sensitivity in the mesolimbic–hypothalamic system have yielded contradictory results. The postsynaptic DA receptor function was evaluated by the cortisol response to apomorphine (APO; 0.75 mg SC) in 16 drug-free DSM-5 major depressed inpatient...

Descripción completa

Detalles Bibliográficos
Autores principales:	Duval, Fabrice, Mokrani, Marie-Claude, Erb, Alexis, Gonzalez Lopera, Felix, Danila, Vlad, Tomsa, Mihaela
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8065982/ https://www.ncbi.nlm.nih.gov/pubmed/33810562 http://dx.doi.org/10.3390/brainsci11040425

Ejemplares similares

Dopamine Function and Hypothalamic-Pituitary-Thyroid Axis Activity in Major Depressed Patients with Suicidal Behavior
por: Duval, Fabrice, et al.
Publicado: (2022)

Dopaminergic, Noradrenergic, Adrenal, and Thyroid Abnormalities in Psychotic and Affective Disorders
por: Duval, Fabrice, et al.
Publicado: (2020)

Effect of repetitive transcranial magnetic stimulation on chronobiological hypothalamic-pituitary-thyroid axis activity in major depression
por: Duval, F., et al.
Publicado: (2023)

Neuroendocrine predictors of the evolution of depression
por: Duval, Fabrice, et al.
Publicado: (2005)

Potential efficacy of dopaminergic antidepressants in treatment resistant anergic-anhedonic depression results of the chronic anergic-anhedonic depression open trial – CADOT
por: Dormegny-Jeanjean, Ludovic Christophe, et al.
Publicado: (2023)

First‐Dose Methylphenidate‐Induced Changes in the Anti‐Saccade Task Performance and Outcome in Adults with Attention‐Deficit/Hyperactivity Disorder
por: Duval, Fabrice, et al.
Publicado: (2021)

Interaction between the serotonergic system and HPA and HPT axes in patients with major depression: implications for pathogenesis of suicidal behavior
por: Duval, Fabrice, et al.
Publicado: (2002)

Serotonergic and noradrenergic function in depression: clinical correlates
por: Duval, Fabrice, et al.
Publicado: (2000)

Systematic Review of the Apomorphine Challenge Test in the Assessment of Dopaminergic Activity in Schizophrenia
por: Duval, Fabrice
Publicado: (2023)

Should antidepressants be used for major depressive disorder?
por: Jakobsen, Janus Christian, et al.
Publicado: (2020)

Translational Identification of Transcriptional Signatures of Major Depression and Antidepressant Response
por: Hervé, Mylène, et al.
Publicado: (2017)

The Roles of BDNF in the Pathophysiology of Major Depression and in Antidepressant Treatment
por: Lee, Bun-Hee, et al.
Publicado: (2010)

Brain Structural Effects of Antidepressant Treatment in Major Depression
por: Dusi, Nicola, et al.
Publicado: (2015)

An electroencephalographic signature predicts antidepressant response in major depression
por: Wu, Wei, et al.
Publicado: (2020)

Brain arousal regulation as response predictor for antidepressant therapy in major depression
por: Schmidt, Frank M., et al.
Publicado: (2017)

ARPNet: Antidepressant Response Prediction Network for Major Depressive Disorder
por: Chang, Buru, et al.
Publicado: (2019)

The effect of antidepressant treatment on white matter integrity in Major Depression
por: Tourjman, S., et al.
Publicado: (2022)

Quantifying the level of difficulty to treat major depressive disorder with antidepressants: Treatment Resistance to Antidepressants Evaluation Scale
por: Liu, Tzu-Yu, et al.
Publicado: (2020)

Genetic Landscape of Major Depressive Disorder: Assessment of Potential Diagnostic and Antidepressant Response Markers
por: Singh, Priyanka, et al.
Publicado: (2023)

Preliminary Pharmacogenetic Study to Explore Putative Dopaminergic Mechanisms of Antidepressant Action
por: Ochi, Taichi, et al.
Publicado: (2021)

Discontinuation of antidepressants after remission with antidepressant medication in major depressive disorder: a systematic review and meta-analysis
por: Kato, Masaki, et al.
Publicado: (2020)

The Use of Antidepressant Drugs and the Lifetime Prevalence of Major Depressive Disorders in Italy
por: Carta, Mauro Giovanni, et al.
Publicado: (2010)

Antidepressant Treatment Normalizes White Matter Volume in Patients with Major Depression
por: Zeng, Ling-Li, et al.
Publicado: (2012)

Antidepressant medication treatment patterns in Asian patients with major depressive disorder
por: Novick, Diego, et al.
Publicado: (2015)

Treatment patterns in major depressive disorder after an inadequate response to first-line antidepressant treatment
por: Garcia-Toro, Mauro, et al.
Publicado: (2012)

The Strategy of Combining Antidepressants in the Treatment of Major Depression: Clinical Experience in Spanish Outpatients
por: Martín-López, Luis M., et al.
Publicado: (2011)

Blue Again: Perturbational Effects of Antidepressants Suggest Monoaminergic Homeostasis in Major Depression
por: Andrews, Paul W., et al.
Publicado: (2011)

Adherence to antidepressant therapy for major depressive patients in a psychiatric hospital in Thailand
por: Prukkanone, Benjamas, et al.
Publicado: (2010)

No Effect of Serotoninergic Gene Variants on Response to Interpersonal Counseling and Antidepressants in Major Depression
por: Serretti, Alessandro, et al.
Publicado: (2013)

New generation multi-modal antidepressants: focus on vortioxetine for major depressive disorder
por: Katona, Cornelius L, et al.
Publicado: (2014)

Pro-Inflammatory Cytokines as Predictors of Antidepressant Effects of Exercise in Major Depressive Disorder
por: Rethorst, Chad D., et al.
Publicado: (2012)

Antidepressants normalize elevated Toll-like receptor profile in major depressive disorder
por: Hung, Yi-Yung, et al.
Publicado: (2015)

Times to Discontinue Antidepressants Over 6 Months in Patients with Major Depressive Disorder
por: Jung, Woo-Young, et al.
Publicado: (2016)

Serum Cytokine Levels in Major Depressive Disorder and Its Role in Antidepressant Response
por: Myung, Woojae, et al.
Publicado: (2016)

Exploring the Role of Gut Microbiota in Major Depressive Disorder and in Treatment Resistance to Antidepressants
por: Fontana, Andrea, et al.
Publicado: (2020)

Antidepressant Drugs and Physical Activity: A Possible Synergism in the Treatment of Major Depression?
por: Guerrera, Claudia Savia, et al.
Publicado: (2020)

Transcranial Magnetic Stimulation Markers of Antidepressant Treatment in Adolescents With Major Depressive Disorder
por: Doruk Camsari, Deniz, et al.
Publicado: (2019)

Increased Cortical Thickness in Patients With Major Depressive Disorder Following Antidepressant Treatment
por: Nemati, Samaneh, et al.
Publicado: (2020)

Potential of Antithrombin III as a Biomarker of Antidepressive Effect in Major Depressive Disorder
por: Song, Ruize, et al.
Publicado: (2021)

Effects of Antidepressant Treatment on Peripheral Biomarkers in Patients with Major Depressive Disorder (MDD)
por: Mosiołek, Anna, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_8t1s0curv3u48afge6r7js1hco